CIK 0001689375 · Accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813983399
- Phone
- 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-05 | Doshi Dipal CEO | Shares withheld for taxes | −5,049 | $12.28 | $62K | 340,375 |
| 2024-03-05 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −1,471 | $12.28 | $18K | 78,256 |
| 2024-03-04 | Doshi Dipal CEO | Shares withheld for taxes | −1,164 | $12.42 | $14K | 346,815 |
| 2024-03-04 | Doshi Dipal CEO | Shares withheld for taxes | −1,391 | $13.37 | $19K | 345,424 |
| 2024-03-04 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −339 | $12.42 | $4K | 80,132 |
| 2024-03-04 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −405 | $13.37 | $5K | 79,727 |
| 2024-03-01 | Doshi Dipal CEO | Grant or award | +104,700 | 347,979 | ||
| 2024-03-01 | Doshi Dipal CEO | Grant or award · Stock Option (Right to Buy) | +158,500 | 158,500 | ||
| 2024-03-01 | WENTWORTH KORY JAMES Chief Financial Officer | Grant or award | +30,900 | 80,471 | ||
| 2024-03-01 | WENTWORTH KORY JAMES Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +46,800 | 46,800 |
Page 12 of 12 · 230 trades